These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9233424)

  • 21. Anti-angiogenic gene therapy in the treatment of malignant gliomas.
    Gatson NN; Chiocca EA; Kaur B
    Neurosci Lett; 2012 Oct; 527(2):62-70. PubMed ID: 22906922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PTK787/ZK222584, an inhibitor of vascular endothelial growth factor receptor tyrosine kinases, decreases glioma growth and vascularization.
    Goldbrunner RH; Bendszus M; Wood J; Kiderlen M; Sasaki M; Tonn JC
    Neurosurgery; 2004 Aug; 55(2):426-32; discussion 432. PubMed ID: 15271251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. KDR activation in astrocytic neoplasms.
    Carroll RS; Zhang J; Bello L; Melnick MB; Maruyama T; McL Black P
    Cancer; 1999 Oct; 86(7):1335-41. PubMed ID: 10506722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of nitric oxide synthase isozymes (NOS I-III) by immunohistochemistry and DNA in situ hybridization. Correlation with macrophage presence, vascular endothelial growth factor (VEGF) and oedema volumetric data in 220 glioblastomas.
    Ludwig HC; Feiz-Erfan I; Bockermann V; Behnke-Mursch J; Schallock K; Markakis E
    Anticancer Res; 2000; 20(1A):299-304. PubMed ID: 10769671
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The gain-of-function GLI1 transcription factor TGLI1 enhances expression of VEGF-C and TEM7 to promote glioblastoma angiogenesis.
    Carpenter RL; Paw I; Zhu H; Sirkisoon S; Xing F; Watabe K; Debinski W; Lo HW
    Oncotarget; 2015 Sep; 6(26):22653-65. PubMed ID: 26093087
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vascular endothelial growth factor-B and vascular endothelial growth factor-C expression in renal cell carcinomas: regulation by the von Hippel-Lindau gene and hypoxia.
    Gunningham SP; Currie MJ; Han C; Turner K; Scott PA; Robinson BA; Harris AL; Fox SB
    Cancer Res; 2001 Apr; 61(7):3206-11. PubMed ID: 11306510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vascular morphology and angiogenesis in glial tumors.
    Plate KH; Mennel HD
    Exp Toxicol Pathol; 1995 May; 47(2-3):89-94. PubMed ID: 7580112
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene expression of VEGF and its receptors Flk-1/KDR and Flt-1 in cultured and transplanted rat islets.
    Vasir B; Jonas JC; Steil GM; Hollister-Lock J; Hasenkamp W; Sharma A; Bonner-Weir S; Weir GC
    Transplantation; 2001 Apr; 71(7):924-35. PubMed ID: 11349728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of in vivo growth of thyroid tumor-derived cell lines by sense and antisense vascular endothelial growth factor gene.
    Belletti B; Ferraro P; Arra C; Baldassarre G; Bruni P; Staibano S; De Rosa G; Salvatore G; Fusco A; Persico MG; Viglietto G
    Oncogene; 1999 Aug; 18(34):4860-9. PubMed ID: 10490819
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The short form of the alternatively spliced flt-4 but not its ligand vascular endothelial growth factor C is related to lymph node metastasis in human breast cancers.
    Gunningham SP; Currie MJ; Han C; Robinson BA; Scott PA; Harris AL; Fox SB
    Clin Cancer Res; 2000 Nov; 6(11):4278-86. PubMed ID: 11106244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of vascular endothelial growth factor (VEGF) and its receptors is regulated in eyes with intra-ocular tumours.
    Stitt AW; Simpson DA; Boocock C; Gardiner TA; Murphy GM; Archer DB
    J Pathol; 1998 Nov; 186(3):306-12. PubMed ID: 10211121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bioactivity of anti-angiogenic ribozymes targeting Flt-1 and KDR mRNA.
    Parry TJ; Cushman C; Gallegos AM; Agrawal AB; Richardson M; Andrews LE; Maloney L; Mokler VR; Wincott FE; Pavco PA
    Nucleic Acids Res; 1999 Jul; 27(13):2569-77. PubMed ID: 10373571
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Up-regulation of flk-1/vascular endothelial growth factor receptor 2 by its ligand in a cerebral slice culture system.
    Kremer C; Breier G; Risau W; Plate KH
    Cancer Res; 1997 Sep; 57(17):3852-9. PubMed ID: 9288799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The anti-angiogenic role of soluble-form VEGF receptor in malignant gliomas.
    Takano S; Ishikawa E; Matsuda M; Sakamoto N; Akutsu H; Yamamoto T; Matsumura A
    Int J Oncol; 2017 Feb; 50(2):515-524. PubMed ID: 28000842
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypoxia-induced VEGF and collagen I expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosis.
    Corpechot C; Barbu V; Wendum D; Kinnman N; Rey C; Poupon R; Housset C; Rosmorduc O
    Hepatology; 2002 May; 35(5):1010-21. PubMed ID: 11981751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent advance in molecular angiogenesis in glioblastoma: the challenge and hope for anti-angiogenic therapy.
    Zhang M; Ye G; Li J; Wang Y
    Brain Tumor Pathol; 2015 Oct; 32(4):229-36. PubMed ID: 26437643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel anti-angiogenic therapies for malignant gliomas.
    Norden AD; Drappatz J; Wen PY
    Lancet Neurol; 2008 Dec; 7(12):1152-60. PubMed ID: 19007739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A plasmid-encoded VEGF siRNA reduces glioblastoma angiogenesis and its combination with interleukin-4 blocks tumor growth in a xenograft mouse model.
    Niola F; Evangelisti C; Campagnolo L; Massalini S; Buè MC; Mangiola A; Masotti A; Maira G; Farace MG; Ciafrè SA
    Cancer Biol Ther; 2006 Feb; 5(2):174-9. PubMed ID: 16340308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. VEGF, flk-1, and flt-1 expression in a rat myocardial infarction model of angiogenesis.
    Li J; Brown LF; Hibberd MG; Grossman JD; Morgan JP; Simons M
    Am J Physiol; 1996 May; 270(5 Pt 2):H1803-11. PubMed ID: 8928889
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene transfer of a soluble receptor of VEGF inhibits the growth of experimental eyelid malignant melanoma.
    Shiose S; Sakamoto T; Yoshikawa H; Hata Y; Kawano Y; Ishibashi T; Inomata H; Takayama K; Ueno H
    Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2395-403. PubMed ID: 10937546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.